207 related articles for article (PubMed ID: 27628318)
21. [Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance].
Chai LX; Sun KL; Guo LP; Zhang HT; Lu SX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):685-8. PubMed ID: 18246799
[TBL] [Abstract][Full Text] [Related]
22. Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.
dos Santos Almeida A; Oliveira DT; Pereira MC; Faustino SE; Nonogaki S; Carvalho AL; Kowalski LP
Anticancer Res; 2013 Sep; 33(9):3969-76. PubMed ID: 24023336
[TBL] [Abstract][Full Text] [Related]
23. Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Wu YC; Chao YK; Liu YH; Tseng CK; Chang HK; Liu HP; Hsueh C
Histol Histopathol; 2009 Aug; 24(8):1021-7. PubMed ID: 19554509
[TBL] [Abstract][Full Text] [Related]
24. Podoplanin expression in cutaneous squamous cell carcinomas and its relationship to histopathological prognostic factors.
Gülseren D; Gököz Ö; Karahan S; Karaduman A
J Histotechnol; 2020 Sep; 43(3):147-152. PubMed ID: 32496961
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
27. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.
Tong L; Yuan S; Feng F; Zhang H
Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849
[TBL] [Abstract][Full Text] [Related]
28. Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung.
Yurugi Y; Wakahara M; Matsuoka Y; Sakabe T; Kubouchi Y; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Jan; 37(1):207-213. PubMed ID: 28011493
[TBL] [Abstract][Full Text] [Related]
29. Podoplanin expression is correlated with the prognosis of lung squamous cell carcinoma.
Ikoma Y; Kijima H; Masuda R; Tanaka M; Inokuchi S; Iwazaki M
Biomed Res; 2015; 36(6):393-402. PubMed ID: 26700593
[TBL] [Abstract][Full Text] [Related]
30. Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C.
Kim HY; Rha KS; Shim GA; Kim JH; Kim JM; Huang SM; Koo BS
Oncol Rep; 2015 Aug; 34(2):833-42. PubMed ID: 26081937
[TBL] [Abstract][Full Text] [Related]
31. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
[TBL] [Abstract][Full Text] [Related]
32. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
34. Association of the co-expression of SOX2 and Podoplanin in the progression of oral squamous cell carcinomas - an immunohistochemical study.
Pradhan S; Guddattu V; Solomon MC
J Appl Oral Sci; 2019 Sep; 27():e20180348. PubMed ID: 31508790
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of FoxP3+ regulatory T cells in lower lip squamous cell carcinomas.
da Cunha FA; Aguiar MC; Souza LB; Pinto LP; Godoy GP; Alves PM; Nonaka CF
Braz Oral Res; 2016 Dec; 30(1):e130. PubMed ID: 28001240
[TBL] [Abstract][Full Text] [Related]
36. Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment.
Suzuki S; Ishii G; Matsuwaki R; Neri S; Hashimoto H; Yamauchi C; Aokage K; Hishida T; Yoshida J; Kohno M; Nagai K; Ochiai A
J Cancer Res Clin Oncol; 2015 Mar; 141(3):475-84. PubMed ID: 25304618
[TBL] [Abstract][Full Text] [Related]
37. Histopathological grading systems and their relationship with clinical parameters in lower lip squamous cell carcinoma.
Santos HB; Silva AL; Cavalcante LH; Alves PM; Godoy GP; Nonaka CF
Int J Oral Maxillofac Surg; 2014 May; 43(5):539-45. PubMed ID: 24289873
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma of the lip: depth of invasion, local recurrence and regional metastases. Experience of a rural multidisciplinary head and neck unit.
Pastuszek A; Hanson M; Grigg R
J Laryngol Otol; 2016 Jan; 130 Suppl 1():S32-7. PubMed ID: 26304159
[TBL] [Abstract][Full Text] [Related]
40. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
